Skip to main content

#153329

HR1 Cell Line

Cat. #153329

HR1 Cell Line

Cat. #: 153329

Sub-type: Continuous

Unit size: 1x10^6 cells / vial

Availability: 10-12 weeks

Organism: Human

Tissue: Kidney

Disease: Cancer

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Simon Cook

Institute: Babraham Institute

Tool Details
Target Details
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: HR1 Cell Line
  • Alternate name: RAF proto-oncogene serine/threonine-protein kinase (EC:2.7.11.1), Proto-oncogene c-RAF, cRaf, Raf-1
  • Research fields: Apoptosis and autophagy;Cancer;Cell biology;Cell signaling and signal transduction;Immunology
  • Tool sub type: Continuous
  • Parental cell: HEK 293
  • Organism: Human
  • Tissue: Kidney
  • Disease: Cancer
  • Growth properties: Adherent cell line
  • Conditional: Yes
  • Conditional description: Stable transfectant, conditional functionality: c-Raf1 kinase activity and ERK1/2 signalling pathway activated following 4-hydroxytamoxifen (4-HT) treatment of cells.
  • Description: HR1 cells are HEK 293 cells stably expressing conditional kinase ∆Raf-1:ER* from the pCMV Neo Myc plasmid. ∆Raf-1:ER* (also known as ∆CRAF:ER*) consists of the isolated kinase domain of c-Raf1 fused in-frame to a modified form of the hormone binding domain of the estrogen receptor (hbER*) that can be de-repressed by 4-hydroxytamoxifen (4-HT) but not β-estradiol. In this case the * refers to a point mutation that ablates estradiol binding but allows 4-HT binding. Activation of ∆Raf-1:ER* leads to the selective activation of the ERK1/2 pathway. This cell line can be used to study the cellular role and factors impacting on the ERK1/2 signalling pathway such as gene expression, cell proliferation, cell cycle arrest and cell death. The cells are G418 resistant. Conditional kinase activation of ∆Raf-1:ER* can be induced with 100nM 4-HT.
  • Production details: HEK 293 cells were transfected with the pCMV Neo Myc plasmid expressing â?‚ˆ?‚†Raf-1:ER*. Stable transfectants were selected by neomycin resistance using G418 (Geneticin) and ring cloning.
  • Cellosaurus id: CVCL_2676

Target Details

  • Target: c-Raf1

Handling

  • Format: Frozen
  • Growth medium: Phenol red-free Dulbecco's modified Eagle's medium (DMEM) high glucose version, 2 mM L-glutamine, 10% fetal bovine serum (FBS), 400 ?g/ml G418 (Geneticin).
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

Related Tools

  • Related tools: HM3 Cell Line

References

  • Gilley et al. 2009. Cell Signal. 21(6):969-77. PMID: 19249353.
  • ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-Fos.
  • Wiggins et al. 2007. Cell Signal. 19(12):2605-11. PMID: 17884340.
  • c-Cbl is not required for ERK1/2-dependent degradation of BimEL.
  • Ewings et al. 2007. EMBO J. 26(12):2856-67. PMID: 17525735.
  • ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL.
  • Boughan et al. 2006. J Biol Chem. 281(1...

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.